Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Serum Mannose-Binding Lectin Levels are Linked with Respiratory Syncytial Virus (RSV) Disease

Abstract

The innate immune response facilitates the quality of the adaptive immune response and is critical to an individual’s susceptibility to infection and disease. Mannose-binding lectin (MBL) is a plasma protein with anti-microbial properties that binds a wide range of pathogens to flag them for immune destruction independent of antibodies. In this study, serum MBL levels were measured in 81 children <5 years old experiencing acute respiratory syncytial virus infection and in 40 control children to determine the association with disease severity. Almost 70% of all RSV-infected children had low to intermediate MBL levels (<500 ng/ml) compared to controls, and most of the <6 months old RSV interned patients had low to intermediate levels. No differences were detected in MBL levels between case and control children <1 month old. Analysis of the T-cell compartment in peripheral blood mononuclear cells (PBMC) from acute RSV-infected and control children showed that the percent CD4+ T cells was statistically lower in RSV-infected children ≥6 months old compared to controls, while the percent CD8+ T cells in RSV-infected and control PBMC was generally similar. These results suggest that low serum MBL levels may be a marker of RSV disease severity in children and that MBL may be important in limiting RSV disease pathogenesis.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2
Fig. 3

References

  1. 1.

    Hacimustafaoglu M, Celebi S, Aynaci E, Sinirtas M, Koksal N, Kucukerdogan A, et al. The progression of maternal RSV antibodies in the offspring. Arch Dis Child. 2004;89(1):52–3.

  2. 2.

    Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543–6.

  3. 3.

    Palomo C, Cane PA, Melero JA. Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains. J Med Virol. 2000;60(4):468–74.

  4. 4.

    Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol. 2000;1(5):398–401.

  5. 5.

    Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, Tripp RA. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J Virol. 2001;75(22):10730–7.

  6. 6.

    Tripp RA. Pathogenesis of respiratory syncytial virus infection. Viral Immunol. 2004;17(2):165–81.

  7. 7.

    Harcourt J, Alvarez R, Jones LP, Henderson C, Anderson LJ, Tripp RA. Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+T cell responses. J Immunol. 2006;176(3):1600–8.

  8. 8.

    Tripp RA, Anderson LJ. Cytotoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine. J Virol. 1998;72(11):8971–5.

  9. 9.

    Tripp RA, Dakhama A, Jones LP, Barskey A, Gelfand EW, Anderson LJ. The G glycoprotein of respiratory syncytial virus depresses respiratory rates through the CX3C motif and substance P. J Virol. 2003;77(11):6580–4.

  10. 10.

    Tripp RA, Jones L, Anderson LJ. Respiratory syncytial virus G and/or SH glycoproteins modify CC and CXC chemokine mRNA expression in the BALB/c mouse. J Virol. 2000;74(13):6227–9.

  11. 11.

    Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ. CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein. Nat Immunol. 2001;2(8):732–8.

  12. 12.

    Tripp RA, Moore D, Winter J, Anderson LJ. Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. J Virol. 2000;74(4):1614–22.

  13. 13.

    Haynes LM, Jones LP, Barskey A, Anderson LJ, Tripp RA. Enhanced disease and pulmonary eosinophilia associated with formalin-inactivated respiratory syncytial virus vaccination are linked to G glycoprotein CX3C-CX3CR1 interaction and expression of substance P. J Virol. 2003;77(18):9831–44.

  14. 14.

    Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol. 1969;89(4):405–21.

  15. 15.

    Chin J, Magoffin RL, Shearer LA, Schieble JH, Lennette EH. Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population. Am J Epidemiol. 1969;89(4):449–63.

  16. 16.

    de Graaff PM, Heidema J, Poelen MC, van Dijk ME, Lukens MV, van Gestel SP, et al. HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells. Virology. 2004;326(2):220–30.

  17. 17.

    Murphy BR, Walsh EE. Formalin-inactivated respiratory syncytial virus vaccine induces antibodies to the fusion glycoprotein that are deficient in fusion-inhibiting activity. J Clin Microbiol. 1988;26(8):1595–7.

  18. 18.

    Piedra PA, Jewell AM, Cron SG, Atmar RL, Glezen WP. Correlates of immunity to respiratory syncytial virus (RSV) associated-hospitalization: establishment of minimum protective threshold levels of serum neutralizing antibodies. Vaccine. 2003;21(24):3479–82.

  19. 19.

    Queiróz DAO, Durigon EL, Botosso VF, Ejzemberg B, Vieira SE, Mineo JR, et al. Immune response to respiratory syncytial virus in young Brazilian children. Braz J Med Biol Res. 2002;35(10):1183–93.

  20. 20.

    van de Wetering JK, van Golde LM, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem. 2004;271(7):1229–49.

  21. 21.

    Endo Y, Takahashi M, Fujita T. Lectin complement system and pattern recognition. Immunobiology. 2006;211(4):283–93.

  22. 22.

    Arnold JN, Dwek RA, Rudd PM, Sim RB. Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett. 2006;106(2):103–10.

  23. 23.

    Gomi K, Tokue Y, Kobayashi T, Takahashi H, Watanabe A, Fujita T, et al. Mannose-binding lectin gene polymorphism is a modulating factor in repeated respiratory infections. Chest. 2004;126(1):95–9.

  24. 24.

    Cedzynski M, Szemraj J, Swierzko AS, Bak-Romaniszyn L, Banasik M, Zeman K, et al. Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system. Clin Exp Immunol. 2004;136(2):304–11.

  25. 25.

    Koch A, Melbye M, Sorensen P, Homoe P, Madsen HO, Molbak K, et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. Jama. 2001;285(10):1316–21.

  26. 26.

    Bouwman LH, Roep BO, Roos A. Mannose-binding lectin: clinical implications for infection, transplantation, and autoimmunity. Hum Immunol. 2006;67(4–5):247–56.

  27. 27.

    Casanova JL, Abel L. Human mannose-binding lectin in immunity: friend, foe, or both? J Exp Med. 2004;199(10):1295–9.

  28. 28.

    Davies J, Turner M, Klein N. The role of the collectin system in pulmonary defence. Paediatr Respir Rev. 2001;2(1):70–5.

  29. 29.

    Openshaw PJ, Tregoning JS. Immune responses and disease enhancement during respiratory syncytial virus infection. Clin Microbiol Rev. 2005;18(3):541–55.

  30. 30.

    Alwan WH, Kozlowska WJ, Openshaw PJ. Distinct types of lung disease caused by functional subsets of antiviral T cells. J Exp Med. 1994;179(1):81–9.

  31. 31.

    Hussell T, Baldwin CJ, O’Garra A, Openshaw PJ. CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection. Eur J Immunol. 1997;27(12):3341–9.

  32. 32.

    Gupta G, Surolia A. Collectins: sentinels of innate immunity. Bioessays. 2007;29(5):452–64.

  33. 33.

    Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology. 2007;212(4–5):381–416.

  34. 34.

    Azevedo AM, Durigon EL, Okasima V, Queiróz DAO, de Moraes-Vasconcelos D, Duarte AJ, et al. Detection of influenza, parainfluenza, adenovirus and respiratory syncytial virus during asthma attacks in children older than 2 years old. Allergol Immunopathol (Madr). 2003;31(6):311–7.

  35. 35.

    Costa LF, Yokosawa J, Mantese OC, Oliveira TFM, Silveira HL, Nepomuceno LL, et al. Respiratory viruses in children younger than five years old with acute respiratory disease from 2001 to 2004 in Uberlandia, MG, Brazil. Mem Inst Oswaldo Cruz. 2006;101(3):301–6.

  36. 36.

    Peret TC, Hall CB, Hammond GW, Piedra PA, Storch GA, Sullender WM, et al. Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America. J Infect Dis. 2000;181(6):1891–6.

  37. 37.

    Thiel S, Frederiksen PD, Jensenius JC. Clinical manifestations of mannan-binding lectin deficiency. Mol Immunol. 2006;43(1–2):86–96.

  38. 38.

    Salkind AR, McCarthy DO, Nichols JE, Domurat FM, Walsh EE, Roberts NJ Jr. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses. J Infect Dis. 1991;163(1):71–7.

  39. 39.

    Azeredo EL, Zagne SM, Alvarenga AR, Nogueira RM, Kubelka CF, de Oliveira-Pinto LM. Activated peripheral lymphocytes with increased expression of cell adhesion molecules and cytotoxic markers are associated with dengue fever disease. Mem Inst Oswaldo Cruz. 2006;101(4):437–49.

  40. 40.

    Tripp RA, Moore D, Barskey At, Jones L, Moscatiello C, Keyserling H, et al. Peripheral blood mononuclear cells from infants hospitalized because of respiratory syncytial virus infection express T helper-1 and T helper-2 cytokines and CC chemokine messenger RNA. J Infect Dis. 2002;185(10):1388–94.

  41. 41.

    Moura FE, Borges LC, Portes SA, Ramos EA, Siqueira MM. Respiratory syncytial virus infections during an epidemic period in Salvador, Brazil. Viral antigenic group analysis and description of clinical and epidemiological aspects. Mem Inst Oswaldo Cruz. 2003;98(6):739–43.

  42. 42.

    Takahashi K, Ip WE, Michelow IC, Ezekowitz RA. The mannose-binding lectin: a prototypic pattern recognition molecule. Curr Opin Immunol. 2006;18(1):16–23.

  43. 43.

    Kristensen IA, Thiel S, Steffensen R, Madhi S, Sorour G, Olsen J. Mannan-binding lectin and RSV lower respiratory tract infection leading to hospitalization in children: a case-control study from Soweto, South Africa. Scand J Immunol. 2004;60(1–2):184–8.

  44. 44.

    Chagas KN, Steffensen R, Ferrao MSC, Dellanegra M, Duarte AS, Rutz R, et al. MBL2 gene and serum MBL levels in Brazilian children. Molecular Immunology. 2004;41(2–3):218–9.

  45. 45.

    Dean MM, Minchinton RM, Heatley S, Eisen DP. Mannose binding lectin acute phase activity in patients with severe infection. J Clin Immunol. 2005;25(4):346–52.

  46. 46.

    Becker Y. Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy—a review. Virus Genes. 2006;33(2):235–52.

Download references

Acknowledgments

The authors acknowledge the contributions of Dr. Dean D. Erdman, Centers for Disease Control and Prevention (CDC), Atlanta, GA, for providing some reagents; Fabiana R. Morais from Centro Regional de Hemoterapia, USP for her technical support; Ariadne Brito for collecting part of the control samples; the laboratories of Immunology, Molecular Biology, Parasitology, Physiology and Genetics, UFU and Centro Regional de Hemoterapia, USP, for their equipments; and the health care professionals of the Hospital de Clínicas for their important contribution.

Author information

Correspondence to Divina Aparecida Oliveira Queiróz.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ribeiro, L.Z.G., Tripp, R.A., Rossi, L.M.G. et al. Serum Mannose-Binding Lectin Levels are Linked with Respiratory Syncytial Virus (RSV) Disease. J Clin Immunol 28, 166–173 (2008). https://doi.org/10.1007/s10875-007-9141-8

Download citation

Keywords

  • Respiratory syncytial virus
  • RSV
  • mannose-binding lectin
  • MBL